ConductScience.org, home

Paper62946

Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.

Lancet, 1976. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Papers, record 62946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62946

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2015-06-16
PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthambutolMajor topic
IsoniazidMajor topic
RifampinMajor topic
StreptomycinMajor topic
Tuberculosis, PulmonaryMajor topic
Adolescent
Adult
Aged
Clinical Trials as Topic
Drug Administration Schedule
Drug Evaluation
Drug Therapy, Combination
Follow-Up Studies
Humans
Middle Aged
Recurrence
Time Factors

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
39993187Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/39993187PubMed
38414662Pyrazinoic acid, the active form of the anti-tuberculosis drug pyrazinamide, and aromatic carboxylic acid analogs are protonophores.Front Mol Biosci2024https://conductscience.org/library/papers/38414662PubMed
29866864Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29866864PubMed
28333978Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey.PLoS One2017https://conductscience.org/library/papers/28333978PubMed
27208770Drug-Resistant Tuberculosis: Challenges and Progress.Infect Dis Clin North Am2016https://conductscience.org/library/papers/27208770PubMed
27184366The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?BMC Infect Dis2016https://conductscience.org/library/papers/27184366PubMed
26574016Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/26574016PubMed
25530919Mechanisms of Pyrazinamide Action and Resistance.Microbiol Spectr2013https://conductscience.org/library/papers/25530919PubMed
23640554Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.Indian J Med Res2013https://conductscience.org/library/papers/23640554PubMed
22664964Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22664964PubMed
19753109Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.PLoS Med2009https://conductscience.org/library/papers/19753109PubMed
16555622Tuberculosis 2004: challenges and opportunities.Trans Am Clin Climatol Assoc2005https://conductscience.org/library/papers/16555622PubMed
8300251Short course intermittent chemotherapy in childhood tuberculosis.Infection1993https://conductscience.org/library/papers/8300251PubMed
7530627Current and potential treatment of tuberculosis.Drugs1994https://conductscience.org/library/papers/7530627PubMed
7382540Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.Lung1980https://conductscience.org/library/papers/7382540PubMed
6884240The case for short-course chemotherapy of pulmonary tuberculosis.Drugs1983https://conductscience.org/library/papers/6884240PubMed
6767845Treatment of tuberculosis. The Mitchell lecture 1979.J R Coll Physicians Lond1980https://conductscience.org/library/papers/6767845PubMed
6749471Short-course therapy for tuberculosis.Drugs1982https://conductscience.org/library/papers/6749471PubMed
6404492New drugs in respiratory disorders.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6404492PubMed
4030288Tuberculosis undefeated.Ir J Med Sci1985https://conductscience.org/library/papers/4030288PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/62946

GET https://conductscience.org/api/papers/v1/62946/cited_by?page=2